MESALAMINE Side Effects

7019857-3 | Alopecia, Blood Culture Positive, Bone Marrow Failure, Dizziness, Escherichia Infection, Parvovirus B19 Test Positive, Upper Respiratory Tract Infection, Viral Infection
on Sep 08, 2010 Female patient from UNITED STATES , 13 years of age, was treated with Mesalamine (View Usage). Patient experienced the following unwanted or unexpected effects: alopecia, blood culture positive, bone marrow failure, dizziness (What is dizziness?), escherichia infection, parvovirus b19 test positive, upper respiratory tract infection, viral infection (What is viral infection?). Mesalamine dosage: Df. During the same period patient was treated with MERCAPTOPURINE (Df/a Few Weeks) (View Mercaptopurine Review and Mercaptopurine Label ), BUDESONIDE (View Budesonide Review and Budesonide Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ). Patient was hospitalized.

7011366-0 | Abdominal Pain, Diarrhoea, Product Quality Issue, Product Taste Abnormal, Weight Increased
Patient was taking Mesalamine (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), diarrhoea, product quality issue, product taste abnormal, weight increased on Sep 22, 2010 from UNITED STATES Additional patient health information: Male patient , 66 years of age, weighting 250.0 lb, was diagnosed with colitis ulcerative and. Mesalamine dosage: 4 Caps 386mg 1 Am Oral.

6994668-3 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Fatigue, Hepatic Enzyme Abnormal, Nausea, Pancytopenia, Renal Failure, White Blood Cell Count Decreased
Adverse event was reported on Sep 08, 2010 by a Female patient taking Mesalamine (View Usage) (Dosage: 4000 Mg, Qd, Oral) was diagnosed with crohn's disease (What is crohn's disease?) and. Location: TURKEY , 37 years of age, After Mesalamine was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, fatigue, hepatic enzyme abnormal, nausea (What is nausea?), pancytopenia, renal failure, white blood cell count decreased. During the same period patient was treated with AZATHIOPRINE (100 Mg, Qd,) (View Azathioprine Review and Azathioprine Label ), MERCAPTOPURINE (100 Mg, Qd, Oral) (View Mercaptopurine Review and Mercaptopurine Label ). Patient was hospitalized.

6967383-X | Foreign Travel, Photodermatosis
on Aug 23, 2010 Male patient from UNITED KINGDOM , 56 years of age, was diagnosed with colitis ulcerative and was treated with Mesalamine (View Usage). Patient experienced the following unwanted or unexpected effects: foreign travel, photodermatosis. Mesalamine dosage: .


6916810-2 | Abdominal Pain, Anal Abscess, Anal Fistula, Blood Culture Positive, Defaecation Urgency, Escherichia Test Positive, Haemoglobin Decreased, Local Swelling, Necrotising Fasciitis
on Jul 28, 2010 Male patient from GREECE , 78 years of age, was diagnosed with colitis and was treated with Mesalamine (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), anal abscess, anal fistula, blood culture positive, defaecation urgency, escherichia test positive, haemoglobin decreased, local swelling, necrotising fasciitis. Mesalamine dosage: 1500 Mg, Qd,; 3000 Mg, Qd,. Patient was hospitalized.

6831063-1 | Biopsy Lung Abnormal, Diffuse Alveolar Damage, Fibrosis, Interstitial Lung Disease, Lower Respiratory Tract Inflammation, Lung Infiltration
Patient was taking Mesalamine (View Usage). After Mesalamine was administered, patient had the following side effects: biopsy lung abnormal, diffuse alveolar damage, fibrosis, interstitial lung disease, lower respiratory tract inflammation, lung infiltration on Jun 27, 2010 from UNITED STATES Additional patient health information: Female patient , 70 years of age, was diagnosed with crohn's disease (What is crohn's disease?) and. Mesalamine dosage: 500 Mg, Qid.

6816820-X | Epstein-barr Virus Infection, Scar, Thrombotic Microangiopathy
Adverse event was reported on Jun 21, 2010 by a Female patient taking Mesalamine (View Usage) (Dosage: ) was diagnosed with colitis ulcerative and. Location: ITALY , 59 years of age, Patient experienced the following unwanted or unexpected effects: epstein-barr virus infection, scar (What is scar?), thrombotic microangiopathy. Patient was hospitalized.

6790043-5 | Anaemia, Chest Pain, Chills, Eosinophilia, Eosinophilic Pneumonia, Haematuria, Hypersensitivity, Leukocyturia, Pericarditis
on Jun 14, 2010 Male patient from ITALY , 42 years of age, was diagnosed with colitis ulcerative and was treated with Mesalamine (View Usage). Patient had the following side effects: anaemia, chest pain (What is chest pain?), chills, eosinophilia, eosinophilic pneumonia, haematuria, hypersensitivity, leukocyturia, pericarditis. Mesalamine dosage: 3.2 G, Qd. During the same period patient was treated with BECLOMETHASONE DIPROPIONATE (Unk) (View Beclomethasone Dipropionate Review and Beclomethasone Dipropionate Label ). Patient was hospitalized.

6784271-2 | Abdominal Pain, Anal Abscess, Anal Fistula, Defaecation Urgency, Escherichia Infection, Local Swelling, Necrotising Fasciitis, Oedema Genital, Post Procedural Complication
on Jun 07, 2010 Male patient from GREECE , 78 years of age, was diagnosed with colitis ulcerative and was treated with Mesalamine (View Usage). After Mesalamine was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), anal abscess, anal fistula, defaecation urgency, escherichia infection, local swelling, necrotising fasciitis, oedema genital, post procedural complication. Mesalamine dosage: 1500 Mg Qd 2000 Mg, Qd. Patient was hospitalized.

6766718-0 | Myopericarditis
Patient was taking Mesalamine (View Usage). Patient experienced the following unwanted or unexpected effects: myopericarditis on Jun 01, 2010 from SPAIN Additional patient health information: Male patient , 22 years of age, was diagnosed with colitis ulcerative and. Mesalamine dosage: 3 G, Qd. Patient was hospitalized.

6760691-7 | Pancreatitis
Adverse event was reported on Jun 07, 2010 by a Male patient taking Mesalamine (View Usage) (Dosage: 1200 Mg Qid Po) was diagnosed with colitis ulcerative and. Location: UNITED STATES , 26 years of age, weighting 186.3 lb, Patient had the following side effects: pancreatitis. Patient was hospitalized.

6738059-9 | Anaemia, Blood Fibrinogen Increased, Blood Lactate Dehydrogenase Increased, Eosinophilic Pneumonia, Fibrin D Dimer Increased, Haematuria, Leukocyturia
on May 10, 2010 Male patient from ITALY , 42 years of age, was diagnosed with colitis ulcerative and was treated with Mesalamine (View Usage). After Mesalamine was administered, patient had the following side effects: anaemia, blood fibrinogen increased, blood lactate dehydrogenase increased, eosinophilic pneumonia, fibrin d dimer increased, haematuria, leukocyturia. Mesalamine dosage: 3200 Mg, Qd. During the same period patient was treated with BECLOMETHASONE DIPROPIONATE (View Beclomethasone Dipropionate Review and Beclomethasone Dipropionate Label ). Patient was hospitalized.

6697642-X | Abdominal Pain, Anaemia, Arthralgia, Biopsy Lip Abnormal, Biopsy Lung Abnormal, Biopsy Skin Abnormal, Blood Alkaline Phosphatase Increased, Bone Scan Abnormal, Cardiac Murmur
on Apr 12, 2010 Male patient from UNITED STATES , 50 years of age, was diagnosed with crohn's disease (What is crohn's disease?) and was treated with Mesalamine (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), anaemia, arthralgia, biopsy lip abnormal, biopsy lung abnormal, biopsy skin abnormal, blood alkaline phosphatase increased, bone scan abnormal, cardiac murmur. Mesalamine dosage: 2000 Mg, Qd. During the same period patient was treated with MERCAPTOPURINE (100 Mg, Qd) (View Mercaptopurine Review and Mercaptopurine Label ), ADALIMUMAB (ADALIMUMAB) (40 Mg, Every 2 Weeks) (View Adalimumab (adalimumab) Review and Adalimumab (adalimumab) Label ).

6696870-7 | Haematochezia
Patient was taking Mesalamine (View Usage). Patient had the following side effects: haematochezia on Mar 18, 2009 from UNITED STATES Additional patient health information: Male patient , 59 years of age, was diagnosed with colitis ulcerative and. Mesalamine dosage: 2.4 G, 1x/day:qd, Oral. During the same period patient was treated with BASALAZINE DISODIUM (BASALAZIDE SODIUM) (View Basalazine Disodium (basalazide Sodium) Review and Basalazine Disodium (basalazide Sodium) Label ), PAROXETINE HCL (View Paroxetine Hcl Review and Paroxetine Hcl Label ), TRAZODONE HCL (View Trazodone Hcl Review and Trazodone Hcl Label ). Patient was hospitalized.

6670894-8 | Abdominal Pain, Condition Aggravated, Diarrhoea Haemorrhagic
Adverse event was reported on Apr 06, 2010 by a Male patient taking Mesalamine (View Usage) (Dosage: 1200 Mg Qid Po) was diagnosed with colitis ulcerative and. Location: UNITED STATES , 38 years of age, After Mesalamine was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), condition aggravated, diarrhoea haemorrhagic. During the same period patient was treated with PREDNISONE (View Prednisone Review and Prednisone Label ), PERCOCET (View Percocet Review and Percocet Label ). Patient was hospitalized.

6637422-4 | Colectomy, Electrocardiogram St-t Change, Muscle Necrosis, Myopathy Toxic, Myositis, Phagocytosis
on Feb 26, 2010 Female patient from JAPAN , child 11 years of age, was diagnosed with colitis ulcerative and was treated with Mesalamine (View Usage). Patient experienced the following unwanted or unexpected effects: colectomy, electrocardiogram st-t change, muscle necrosis, myopathy toxic, myositis (What is myositis?), phagocytosis. Mesalamine dosage: (2000 Mg Qd). During the same period patient was treated with SULFASALAZINE ((df)) (View Sulfasalazine Review and Sulfasalazine Label ).

6610149-0 | Acute Phase Reaction, Dilatation Ventricular, Myopericarditis, Pericardial Effusion, Pleuritic Pain, Rectal Haemorrhage, Troponin T Increased, Ventricular Dysfunction, White Blood Cell Count Increased
on Feb 09, 2010 Female patient from SPAIN , 22 years of age, was diagnosed with abdominal pain (What is abdominal pain?), gastrointestinal disorder and was treated with Mesalamine (View Usage). Patient had the following side effects: acute phase reaction, dilatation ventricular, myopericarditis, pericardial effusion, pleuritic pain, rectal haemorrhage, troponin t increased, ventricular dysfunction, white blood cell count increased. Mesalamine dosage: 3 G, Qd,. Patient was hospitalized.

6551419-4 | Arthralgia, Colitis, Influenza, Pleural Effusion, Pleurisy
Patient was taking Mesalamine (View Usage). After Mesalamine was administered, patient had the following side effects: arthralgia, colitis, influenza, pleural effusion, pleurisy on Jan 08, 2010 from ITALY Additional patient health information: Male patient , 23 years of age, . Mesalamine dosage: Df Rectal, 2.4 G, Total Daily Dose Oral, 2.4 G, Total Daily Dose Oral.

6551368-1 | Cough, Lung Infiltration, Lung Neoplasm, Mediastinal Disorder, Nodule, Pulmonary Vasculitis, Pyrexia
Adverse event was reported on Jan 08, 2010 by a Female patient taking Mesalamine (View Usage) (Dosage: 300 Mg Tid) was diagnosed with colitis ulcerative and. Location: ISRAEL , 25 years of age, Patient experienced the following unwanted or unexpected effects: cough, lung infiltration, lung neoplasm, mediastinal disorder, nodule, pulmonary vasculitis, pyrexia. Patient was hospitalized.

6551130-X | Photosensitivity Reaction
on Jan 14, 2010 Female patient from UNITED KINGDOM , 65 years of age, weighting 176.4 lb, was diagnosed with proctitis ulcerative and was treated with Mesalamine (View Usage). Patient had the following side effects: photosensitivity reaction. Mesalamine dosage: 1.2 G, 2x/day:bid, Oral. During the same period patient was treated with PENTASA (View Pentasa Review and Pentasa Label ).

6528751-3 | Obstructive Airways Disorder, Paraesthesia Oral
on Dec 22, 2009 Male patient from UNITED KINGDOM , 72 years of age, was diagnosed with colitis ulcerative and was treated with Mesalamine (View Usage). After Mesalamine was administered, patient had the following side effects: obstructive airways disorder, paraesthesia oral. Mesalamine dosage: .

6457465-3 | Antineutrophil Cytoplasmic Antibody Positive, Antinuclear Antibody Increased, Haemoglobin Decreased, Platelet Count Increased, Pulmonary Vasculitis
Patient was taking Mesalamine (View Usage). Patient experienced the following unwanted or unexpected effects: antineutrophil cytoplasmic antibody positive, antinuclear antibody increased, haemoglobin decreased, platelet count increased, pulmonary vasculitis on Nov 07, 2009 from ISRAEL Additional patient health information: Female patient , 25 years of age, was diagnosed with colitis ulcerative and. Mesalamine dosage: 300 Mg, Tid. Patient was hospitalized.

6431798-9 | Myocarditis, Syncope, Trifascicular Block, Ventricular Hypertrophy
Adverse event was reported on Oct 20, 2009 by a Male patient taking Mesalamine (View Usage) (Dosage: Df) was diagnosed with crohn's disease (What is crohn's disease?) and. Location: SPAIN , 36 years of age, Patient had the following side effects: myocarditis, syncope, trifascicular block, ventricular hypertrophy. During the same period patient was treated with PREDNISONE (View Prednisone Review and Prednisone Label ). Patient was hospitalized.

6421669-6 | Abdominal Pain Upper, Nausea, Pancreatitis Acute
on Oct 29, 2009 Male patient from UNITED STATES , 21 years of age, was diagnosed with colitis ulcerative and was treated with Mesalamine (View Usage). After Mesalamine was administered, patient had the following side effects: abdominal pain upper, nausea (What is nausea?), pancreatitis acute. Mesalamine dosage: .

6419448-9 | Haemoglobin Abnormal, Interstitial Lung Disease, Mean Cell Haemoglobin Concentration Abnormal, Mean Cell Volume Abnormal, Platelet Count Abnormal, Red Blood Cell Count Abnormal, White Blood Cell Count Abnormal
on Oct 16, 2009 Female patient from ITALY , 32 years of age, was diagnosed with colitis ulcerative and was treated with Mesalamine (View Usage). Patient experienced the following unwanted or unexpected effects: haemoglobin abnormal, interstitial lung disease, mean cell haemoglobin concentration abnormal, mean cell volume abnormal, platelet count abnormal, red blood cell count abnormal, white blood cell count abnormal. Mesalamine dosage: . Patient was hospitalized.

6419445-3 | Interstitial Lung Disease
Patient was taking Mesalamine (View Usage). Patient had the following side effects: interstitial lung disease on Oct 14, 2009 from JAPAN Additional patient health information: Female patient , 50 years of age, was diagnosed with colitis ulcerative and. Mesalamine dosage: Oral. Patient was hospitalized.

6419443-X | Condition Aggravated, Eosinophilia, Infection Parasitic, Inflammatory Bowel Disease, White Blood Cell Count Increased
Adverse event was reported on Oct 14, 2009 by a Male patient taking Mesalamine (View Usage) (Dosage: 30 Mg/kg, Tid, Oral) was diagnosed with inflammatory bowel disease and. Location: TURKEY , child 9 years of age, After Mesalamine was administered, patient had the following side effects: condition aggravated, eosinophilia, infection parasitic, inflammatory bowel disease, white blood cell count increased. During the same period patient was treated with METRONIDAZOLE (View Metronidazole Review and Metronidazole Label ).

6403502-1 | Asthenia, Colitis Ulcerative, Condition Aggravated, Diarrhoea Haemorrhagic, Fibrosing Colonopathy, Gastrointestinal Sounds Abnormal, Weight Decreased
on Sep 29, 2009 Male patient from SPAIN , child 10 years of age, was diagnosed with colitis and was treated with Mesalamine (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, colitis ulcerative, condition aggravated, diarrhoea haemorrhagic, fibrosing colonopathy, gastrointestinal sounds abnormal, weight decreased. Mesalamine dosage: 500 Mg, Tid,; 1000 Mg,tid,. During the same period patient was treated with PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ). Patient was hospitalized.

6334467-9 | Cutaneous Vasculitis, Granuloma Skin, Treatment Failure
on Aug 14, 2009 Female patient from UNITED STATES , 42 years of age, was diagnosed with colitis ulcerative and was treated with Mesalamine (View Usage). Patient had the following side effects: cutaneous vasculitis, granuloma skin, treatment failure. Mesalamine dosage: . During the same period patient was treated with BALSALAZIDE (BALSALAZIDE) (View Balsalazide (balsalazide) Review and Balsalazide (balsalazide) Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ).

6327973-4 | Anxiety, Asthenia, Blood Glucose Increased, Blood Potassium Decreased, Blood Sodium Decreased, Condition Aggravated, Decreased Appetite, Haemoglobin Decreased, Hypophagia
Patient was taking Mesalamine (View Usage). After Mesalamine was administered, patient had the following side effects: anxiety (What is anxiety?), asthenia, blood glucose increased, blood potassium decreased, blood sodium decreased, condition aggravated, decreased appetite, haemoglobin decreased, hypophagia on Aug 12, 2009 from INDIA Additional patient health information: Male patient , weighting 119.0 lb, was diagnosed with colitis ulcerative and. Mesalamine dosage: (2.4 G Qd Oral). During the same period patient was treated with ROZO (View Rozo Review and Rozo Label ), CROCIN (View Crocin Review and Crocin Label ), RABIUM (View Rabium Review and Rabium Label ), MECOREURON (View Mecoreuron Review and Mecoreuron Label ), FOHITE (View Fohite Review and Fohite Label ), LEVOCETZINE (View Levocetzine Review and Levocetzine Label ), AMARYL (View Amaryl Review and Amaryl Label ), GLUCOPHAGE (View Glucophage Review and Glucophage Label ). Patient was hospitalized.

6327882-0 | Anaemia, Disease Progression
Adverse event was reported on Aug 12, 2009 by a Male patient taking Mesalamine (View Usage) (Dosage: (2.4 G Qd Oral)) was diagnosed with colitis ulcerative and. Location: INDIA , weighting 172.0 lb, Patient experienced the following unwanted or unexpected effects: anaemia, disease progression. Patient was hospitalized.

6287125-3 | Anaemia, Erythema Nodosum, Pallor, Pyrexia, Renal Impairment, Tubulointerstitial Nephritis, Weight Decreased
on Jun 09, 2009 Male patient from CZECH REPUBLIC , 15 years of age, weighting 102.5 lb, was diagnosed with proctocolitis and was treated with Mesalamine (View Usage). Patient had the following side effects: anaemia, erythema nodosum, pallor, pyrexia, renal impairment, tubulointerstitial nephritis, weight decreased. Mesalamine dosage: (3 G Qd). During the same period patient was treated with AZATHIOPRINE (View Azathioprine Review and Azathioprine Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ).

6219940-6 | Anaemia
on Jun 04, 2009 Male patient from INDIA , weighting 172.0 lb, was diagnosed with colitis ulcerative and was treated with Mesalamine (View Usage). After Mesalamine was administered, patient had the following side effects: anaemia. Mesalamine dosage: (2 Df Qd Oral). Patient was hospitalized.

6203018-1 | Acute Febrile Neutrophilic Dermatosis
Patient was taking Mesalamine (View Usage). Patient experienced the following unwanted or unexpected effects: acute febrile neutrophilic dermatosis on Apr 29, 2009 from UNITED STATES Additional patient health information: Male patient , 40 years of age, was diagnosed with colitis ulcerative and. Mesalamine dosage: . During the same period patient was treated with AZATHIOPRINE (View Azathioprine Review and Azathioprine Label ), CORTICOSTEROIDS. (View Corticosteroids. Review and Corticosteroids. Label ).

6202870-3 | Anaemia, Erythema Nodosum, Leukocyturia, Oedema, Pallor, Pyrexia, Tubulointerstitial Nephritis, Weight Decreased
Adverse event was reported on May 11, 2009 by a Male patient taking Mesalamine (View Usage) (Dosage: 3 G, Qd, Rectal) was diagnosed with proctocolitis and. Location: CZECH REPUBLIC , 15 years of age, weighting 112.4 lb, Patient had the following side effects: anaemia, erythema nodosum, leukocyturia, oedema, pallor, pyrexia, tubulointerstitial nephritis, weight decreased. During the same period patient was treated with AZATHIOPRINE (View Azathioprine Review and Azathioprine Label ), PREDNISOLONE ACETATE (View Prednisolone Acetate Review and Prednisolone Acetate Label ). Patient was hospitalized.

6181465-4 | Anaemia, Blood Calcium Decreased, Blood Chloride Decreased, Blood Glucose Increased, Blood Sodium Decreased, Colitis Ulcerative, Feeling Abnormal, Hair Metal Test Abnormal, Lymphocyte Percentage Decreased
on Apr 22, 2009 Male patient from POLAND , weighting 172.0 lb, was diagnosed with colitis ulcerative and was treated with Mesalamine (View Usage). After Mesalamine was administered, patient had the following side effects: anaemia, blood calcium decreased, blood chloride decreased, blood glucose increased, blood sodium decreased, colitis ulcerative, feeling abnormal, hair metal test abnormal, lymphocyte percentage decreased. Mesalamine dosage: (2 Df Qd Oral). Patient was hospitalized.

6157140-9 | Bone Marrow Eosinophilic Leukocyte Count Increased, Condition Aggravated, Eosinophilia, Inflammatory Bowel Disease, White Blood Cell Count Increased
on Apr 08, 2009 Male patient from TURKEY , child 7 years of age, was diagnosed with inflammatory bowel disease and was treated with Mesalamine (View Usage). Patient experienced the following unwanted or unexpected effects: bone marrow eosinophilic leukocyte count increased, condition aggravated, eosinophilia, inflammatory bowel disease, white blood cell count increased. Mesalamine dosage: 30 Mg/kg, 3 Times Daily, Oral. Patient was hospitalized.

6150211-2 | Eye Disorder, Ophthalmoplegia, Polyneuropathy
Patient was taking Mesalamine (View Usage). Patient had the following side effects: eye disorder, ophthalmoplegia, polyneuropathy on Apr 06, 2009 from GERMANY Additional patient health information: Female patient , 68 years of age, was diagnosed with colitis ulcerative and. Mesalamine dosage: 3 Mg, Oral. During the same period patient was treated with CARBAMAZEPINE (View Carbamazepine Review and Carbamazepine Label ). Patient was hospitalized.

6148948-4 | Arthralgia, Colitis, Influenza, Pleural Effusion, Pleurisy
Adverse event was reported on Mar 26, 2009 by a Male patient taking Mesalamine (View Usage) (Dosage: 2.4 G, 1x/day:qd, Oral) was diagnosed with colitis ulcerative and. Location: ITALY , 23 years of age, After Mesalamine was administered, patient had the following side effects: arthralgia, colitis, influenza, pleural effusion, pleurisy. During the same period patient was treated with METHYLPREDNISOLONE 16MG TAB (View Methylprednisolone 16mg Tab Review and Methylprednisolone 16mg Tab Label ).

6148459-6 | Arteriosclerosis Coronary Artery, Influenza Like Illness, Myalgia, Myocardial Infarction, Myocardial Ischaemia, Pyrexia
on Mar 25, 2009 Male patient from FRANCE , 50 years of age, was diagnosed with crohn's disease (What is crohn's disease?) and was treated with Mesalamine (View Usage). Patient experienced the following unwanted or unexpected effects: arteriosclerosis coronary artery, influenza like illness, myalgia, myocardial infarction, myocardial ischaemia, pyrexia. Mesalamine dosage: (df). Patient was hospitalized.

6148297-4 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Bilirubin Increased, Blood Lactate Dehydrogenase Increased, Fatigue, Gait Disturbance, Haemoglobin Decreased, Hypophagia, Lip Erosion
on Oct 21, 2008 Female patient from UNITED STATES , 29 years of age, was diagnosed with crohn's disease (What is crohn's disease?) and was treated with Mesalamine (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, blood lactate dehydrogenase increased, fatigue, gait disturbance, haemoglobin decreased, hypophagia, lip erosion. Mesalamine dosage: 2000 Mg, Bid;. During the same period patient was treated with MERCAPTOPURINE (100 Mg To 150 Mg Daily - Steroid-sparing Agent)) (View Mercaptopurine Review and Mercaptopurine Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), CHLORDIAZEPOXIDE (View Chlordiazepoxide Review and Chlordiazepoxide Label ), CLIDINIUM BROMIDE (View Clidinium Bromide Review and Clidinium Bromide Label ). Patient was hospitalized.

6140178-5 | Anaemia, Disease Progression
Patient was taking Mesalamine (View Usage). After Mesalamine was administered, patient had the following side effects: anaemia, disease progression on Mar 24, 2009 from INDIA Additional patient health information: Male patient , weighting 172.0 lb, was diagnosed with colitis ulcerative and. Mesalamine dosage: (2 Df Qd Oral). Patient was hospitalized.

6129770-1 | Arteriosclerosis Coronary Artery, Influenza Like Illness, Ischaemic Cardiomyopathy, Myocardial Infarction, Myocarditis
Adverse event was reported on Mar 04, 2009 by a Male patient taking Mesalamine (View Usage) (Dosage: Df) was diagnosed with crohn's disease (What is crohn's disease?) and. Location: FRANCE , 50 years of age, Patient experienced the following unwanted or unexpected effects: arteriosclerosis coronary artery, influenza like illness, ischaemic cardiomyopathy, myocardial infarction, myocarditis. Patient was hospitalized.

6120961-2 | Anaemia, Disease Progression
on Mar 04, 2009 Male patient from INDIA , weighting 172.0 lb, was diagnosed with colitis ulcerative and was treated with Mesalamine (View Usage). Patient had the following side effects: anaemia, disease progression. Mesalamine dosage: (2 Df Qd Oral). Patient was hospitalized.

6120917-X | Anaemia, Band Neutrophil Count Increased, Blood Calcium Decreased, Blood Chloride Decreased, Blood Glucose Increased, Blood Lactic Acid Increased, Blood Sodium Decreased, Feeling Abnormal, Hair Metal Test Abnormal
on Mar 05, 2009 Male patient from POLAND , weighting 172.0 lb, was diagnosed with colitis ulcerative and was treated with Mesalamine (View Usage). After Mesalamine was administered, patient had the following side effects: anaemia, band neutrophil count increased, blood calcium decreased, blood chloride decreased, blood glucose increased, blood lactic acid increased, blood sodium decreased, feeling abnormal, hair metal test abnormal. Mesalamine dosage: 2 Df Qd Oral. Patient was hospitalized.

6105718-0 | Diarrhoea
Patient was taking Mesalamine (View Usage). Patient experienced the following unwanted or unexpected effects: diarrhoea on Mar 04, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 133.3 lb, . Mesalamine dosage: 400mg Tablet Dr 400 Mg Tid Oral. During the same period patient was treated with ATENOLOL (View Atenolol Review and Atenolol Label ), EVISTA (View Evista Review and Evista Label ), LEVOXYL (View Levoxyl Review and Levoxyl Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), MVI (MULTIVITAMINS) (View Mvi (multivitamins) Review and Mvi (multivitamins) Label ).

6104085-6 | Arthralgia, Colitis Ulcerative, Cross Sensitivity Reaction, Disease Recurrence, Dyspnoea Exertional, Malabsorption, Pleural Effusion
Adverse event was reported on Feb 16, 2009 by a Male patient taking Mesalamine (View Usage) (Dosage: 2.4 G/day, Oral) was diagnosed with colitis ulcerative, influenza and. Location: ITALY , 23 years of age, Patient had the following side effects: arthralgia, colitis ulcerative, cross sensitivity reaction, disease recurrence, dyspnoea exertional, malabsorption, pleural effusion. During the same period patient was treated with ACETYLSALICYLIC ACID SRT (300 Mg,) (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ).

6103140-4 | Dehydration, Electrolyte Imbalance, Infection, Pyrexia
on Feb 25, 2009 Male patient from DENMARK , 66 years of age, was diagnosed with colitis collagenous and was treated with Mesalamine (View Usage). After Mesalamine was administered, patient had the following side effects: dehydration, electrolyte imbalance, infection (What is infection?), pyrexia. Mesalamine dosage: 3 Gm (3 Gm, 1 In 1 D), Oral. During the same period patient was treated with SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), MAGNYL (ACETYLSALICYLIC ACID) (View Magnyl (acetylsalicylic Acid) Review and Magnyl (acetylsalicylic Acid) Label ), BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ). Patient was hospitalized.

6093178-8 | Tolosa-hunt Syndrome
on Feb 19, 2009 Female patient from GERMANY , 68 years of age, was diagnosed with colitis ulcerative and was treated with Mesalamine (View Usage). Patient experienced the following unwanted or unexpected effects: tolosa-hunt syndrome. Mesalamine dosage: 3 Gm Oral. During the same period patient was treated with CARBAMAZEPINE (View Carbamazepine Review and Carbamazepine Label ). Patient was hospitalized.

6079636-0 | Agranulocytosis
Patient was taking Mesalamine (View Usage). Patient had the following side effects: agranulocytosis on Feb 10, 2009 from UNITED KINGDOM Additional patient health information: Male patient , 81 years of age, was diagnosed with colitis ulcerative and. Mesalamine dosage: . During the same period patient was treated with MADOPAR (View Madopar Review and Madopar Label ), CODEINE PHOSPHATE (View Codeine Phosphate Review and Codeine Phosphate Label ), METRONIDAZOLE (View Metronidazole Review and Metronidazole Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), PARACETAMOL (View Paracetamol Review and Paracetamol Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ). Patient was hospitalized.